Literature DB >> 8237060

Metabolism of Casodex in laboratory animals.

G W Boyle1, D McKillop, P J Phillips, J R Harding, R Pickford, A D McCormick.   

Abstract

1. Casodex, a non-steroidal antiandrogen, was eliminated primarily in faeces by rat, mouse, rabbit and dog. Rat, mouse and rabbit eliminated 20-30% of a single oral dose (8-25 mg/kg) in urine; only 3-4% was excreted in urine by dog (2.5 mg/kg). Oral absorption was about 80% in rat, mouse, rabbit and dog. 2. Most of the dose was recovered in 48 h from rat, mouse and rabbit. In rat, < 1% of the dose was exhaled as 14CO2 and < 1% remained in the carcass after 7 days. Recovery from dog was incomplete in 4 days but consistent with the long plasma elimination half-life of 7-7.5 days. Casodex was eliminated from rat plasma with a half-life of 17-21 h. 3. Examination of urine indicated extensive metabolism of Casodex and showed a marked species difference. In rat, mouse and dog, Casodex was cleaved at the amide to yield a carboxylic acid and an aromatic amine which subsequently underwent ring hydroxylation with sulphate conjugation. In rabbit, the major urinary metabolite was Casodex glucuronide, conjugated on the tertiary hydroxyl. 4. The major component in faeces of all species was unchanged Casodex; some hydroxy-Casodex was also observed in rat faeces. Analysis of rat and dog bile indicated that Casodex and hydroxy-Casodex were eliminated in bile primarily as glucuronide conjugates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8237060     DOI: 10.3109/00498259309166784

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  7 in total

Review 1.  Chemistry and structural biology of androgen receptor.

Authors:  Wenqing Gao; Casey E Bohl; James T Dalton
Journal:  Chem Rev       Date:  2005-09       Impact factor: 60.622

2.  Interspecies differences in pharmacokinetics and metabolism of S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethylphenyl)-propionamide: the role of N-acetyltransferase.

Authors:  Wenqing Gao; Jeffrey S Johnston; Duane D Miller; James T Dalton
Journal:  Drug Metab Dispos       Date:  2005-11-04       Impact factor: 3.922

3.  Characterization of the in vitro metabolism of selective androgen receptor modulator using human, rat, and dog liver enzyme preparations.

Authors:  Wenqing Gao; Zengru Wu; Casey E Bohl; Jun Yang; Duane D Miller; James T Dalton
Journal:  Drug Metab Dispos       Date:  2005-11-04       Impact factor: 3.922

Review 4.  Bicalutamide: clinical pharmacokinetics and metabolism.

Authors:  Ian D Cockshott
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

5.  Pharmacokinetics and metabolism of a selective androgen receptor modulator in rats: implication of molecular properties and intensive metabolic profile to investigate ideal pharmacokinetic characteristics of a propanamide in preclinical study.

Authors:  Di Wu; Zengru Wu; Jun Yang; Vipin A Nair; Duane D Miller; James T Dalton
Journal:  Drug Metab Dispos       Date:  2005-12-28       Impact factor: 3.922

Review 6.  Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands.

Authors:  Wenqing Gao; Juhyun Kim; James T Dalton
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

7.  Pharmacokinetics of S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro- 3-trifluoromethyl-phenyl)-propionamide in rats, a non-steroidal selective androgen receptor modulator.

Authors:  J D Kearbey; D Wu; W Gao; D D Miller; J T Dalton
Journal:  Xenobiotica       Date:  2004-03       Impact factor: 1.908

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.